Testing hypotheses about the relationship between cannabis use and psychosis
- PMID:12821204
- DOI: 10.1016/s0376-8716(03)00064-4
Testing hypotheses about the relationship between cannabis use and psychosis
Abstract
Aim: To model the impact of rising rates of cannabis use on the incidence and prevalence of psychosis under four hypotheses about the relationship between cannabis use and psychosis.
Methods: The study modelled the effects on the prevalence of schizophrenia over the lifespan of cannabis in eight birth cohorts: 1940-1944, 1945-1949, 1950-1954, 1955-1959, 1960-1964, 1965-1969, 1970-1974, 1975-1979. It derived predictions as to the number of cases of schizophrenia that would be observed in these birth cohorts, given the following four hypotheses: (1) that there is a causal relationship between cannabis use and schizophrenia; (2) that cannabis use precipitates schizophrenia in vulnerable persons; (3) that cannabis use exacerbates schizophrenia; and (4) that persons with schizophrenia are more liable to become regular cannabis users.
Results: There was a steep rise in the prevalence of cannabis use in Australia over the past 30 years and a corresponding decrease in the age of initiation of cannabis use. There was no evidence of a significant increase in the incidence of schizophrenia over the past 30 years. Data on trends the age of onset of schizophrenia did not show a clear pattern. Cannabis use among persons with schizophrenia has consistently been found to be more common than in the general population.
Conclusions: Cannabis use does not appear to be causally related to the incidence of schizophrenia, but its use may precipitate disorders in persons who are vulnerable to developing psychosis and worsen the course of the disorder among those who have already developed it.
Similar articles
- Cannabis and psychosis.Degenhardt L, Hall W.Degenhardt L, et al.Curr Psychiatry Rep. 2002 Jun;4(3):191-6. doi: 10.1007/s11920-002-0026-5.Curr Psychiatry Rep. 2002.PMID:12003681Review.
- Cannabis use and psychotic disorders: an update.Hall W, Degenhardt L, Teesson M.Hall W, et al.Drug Alcohol Rev. 2004 Dec;23(4):433-43. doi: 10.1080/09595230412331324554.Drug Alcohol Rev. 2004.PMID:15763748Review.
- [Cannabis and psychosis--a review].Schaub M, Rössler W, Stohler R.Schaub M, et al.Praxis (Bern 1994). 2004 Jun 2;93(23):997-1002. doi: 10.1024/0369-8394.93.23.997.Praxis (Bern 1994). 2004.PMID:15233568Review.German.
- Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales.Hickman M, Vickerman P, Macleod J, Kirkbride J, Jones PB.Hickman M, et al.Addiction. 2007 Apr;102(4):597-606. doi: 10.1111/j.1360-0443.2006.01710.x.Addiction. 2007.PMID:17362293
- Annual incidence of cannabis-induced psychosis, other substance-induced psychoses and dually diagnosed schizophrenia and cannabis use disorder in Denmark from 1994 to 2016.Hjorthøj C, Larsen MO, Starzer MSK, Nordentoft M.Hjorthøj C, et al.Psychol Med. 2021 Mar;51(4):617-622. doi: 10.1017/S0033291719003532. Epub 2019 Dec 16.Psychol Med. 2021.PMID:31839011
Cited by
- MAPK14 and CNR1 gene variant interactions: effects on brain volume deficits in schizophrenia patients with marijuana misuse.Onwuameze OE, Nam KW, Epping EA, Wassink TH, Ziebell S, Andreasen NC, Ho BC.Onwuameze OE, et al.Psychol Med. 2013 Mar;43(3):619-31. doi: 10.1017/S0033291712001559. Epub 2012 Jul 31.Psychol Med. 2013.PMID:22850347Free PMC article.
- Amphetamine-induced psychosis--a separate diagnostic entity or primary psychosis triggered in the vulnerable?Bramness JG, Gundersen ØH, Guterstam J, Rognli EB, Konstenius M, Løberg EM, Medhus S, Tanum L, Franck J.Bramness JG, et al.BMC Psychiatry. 2012 Dec 5;12:221. doi: 10.1186/1471-244X-12-221.BMC Psychiatry. 2012.PMID:23216941Free PMC article.Review.
- Keep off the grass? Cannabis, cognition and addiction.Curran HV, Freeman TP, Mokrysz C, Lewis DA, Morgan CJ, Parsons LH.Curran HV, et al.Nat Rev Neurosci. 2016 May;17(5):293-306. doi: 10.1038/nrn.2016.28. Epub 2016 Apr 7.Nat Rev Neurosci. 2016.PMID:27052382Review.
- Vulnerability Factors for the Psychiatric and Behavioral Effects of Cannabis.Bortolato M, Bini V, Tambaro S.Bortolato M, et al.Pharmaceuticals (Basel). 2010 Aug 26;3(9):2799-2820. doi: 10.3390/ph3092799.Pharmaceuticals (Basel). 2010.PMID:27713377Free PMC article.Review.
- Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models.Malone DT, Hill MN, Rubino T.Malone DT, et al.Br J Pharmacol. 2010 Jun;160(3):511-22. doi: 10.1111/j.1476-5381.2010.00721.x.Br J Pharmacol. 2010.PMID:20590561Free PMC article.Review.
MeSH terms
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous